Patent details

EP2803367 Title: Methods of treatment using anti-ERBB antibody-maytansinoid conjugates

Basic Information

Publication number:
EP2803367
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Expired
Application number:
EP141691782
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Methods of treatment using anti-ERBB antibody-maytansinoid conjugates
French Title of Invention:
Procédés de traitement utilisant des conjugués maytansinoïdes-anticorps anti-erbb
German Title of Invention:
Verfahren zur Behandlung mithilfe von Anti-ERBB-Anitkörper-Maytansionoid-Konjugaten
SPC Number:

Dates

Filing date:
23/06/2000
Grant date:
31/01/2018
EP Publication Date:
19/11/2014
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
31/01/2018
EP B1 Publication Date:
31/01/2018
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
23/06/2020
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
24/01/2018
 
 

Name:
ImmunoGen, Inc.
Address:
830 Winter Street, Waltham, MA 02451-1477, United States (US)

Agent

Name:
Office FREYLINGER S.A.
From:
14/03/2018
Address:
PO Box 48, 8001, STRASSEN, Luxembourg (LU)
To:

Inventor

Name:
Blattler, Dr. Walter
Address:
United States (US)

Priority

1

Priority Number:
141316 P
Priority Date:
25/06/1999
Priority Country:
United States (US)

2

Priority Number:
189844 P
Priority Date:
16/03/2000
Priority Country:
United States (US)

Classification

IPC classification:
A61K 47/68;

Publication

European Patent Bulletin

1

Issue number:
201805
Publication date:
31/01/2018
Description:
Grant (B1)

2

Issue number:
201901
Publication date:
02/01/2019
Description:
International Patent Classification Changed

3

Issue number:
201907
Publication date:
13/02/2019
Description:
International Patent Classification Changed

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
04/06/2019
Last Annual Fee Paid Number:
20
Last Annual Fee Paid Amount:
300 Euro
Payer:
MDC (HENKEL PATENT)
Filing date Document type Number of pages
28/03/2018 Outgoing Correspondence 1
14/03/2018 Power Of Attorney 1